1. NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
   Antonio Lucena-Cacace et al, 2019, Frontiers in Oncology CrossRef
2. Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
   Ubaldina Galli et al, 2020, Frontiers in Pharmacology CrossRef
3. Advances in NAD-Lowering Agents for Cancer Treatment
   Moustafa S. Ghanem et al, 2021, Nutrients CrossRef
4. Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance
   Travis C. Salzillo et al, 2021, Cells CrossRef
5. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death
   Ganga Reddy Velma et al, 2024, Journal of Medicinal Chemistry CrossRef
6. Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment
   QinChen Xu et al, 2022, Cancer Cell International CrossRef
7. microRNA‑15a‑5p participates in sepsis by regulating the inflammatory response of macrophages and targeting TNIP2
   Yufeng Lou et al, 2020, Experimental and Therapeutic Medicine CrossRef
8. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
   Lola E. Navas et al, 2022, Cells CrossRef
9. Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway
   Jun Feng et al, 2016, BioMed Research International CrossRef
10. Visfatin, Obesity, and Cancer
    Maria Dalamaga et al, 2017, Adipocytokines, Energy Balance, and Cancer CrossRef
11. Obesity Potentiates Esophageal Squamous Cell Carcinoma Growth and Invasion by AMPK-YAP Pathway
    Jia-Huang Liu et al, 2020, Journal of Immunology Research CrossRef
12. Sirtuin 1 participates in intervertebral disc degeneration via the nicotinamide phosphoribosyl transferase/nicotinamide adenine dinucleotide/sirtuin 1 pathway responsible for regulating autophagy of nucleus pulposus cells
    Qifeng Shi et al, 2022, Experimental and Therapeutic Medicine CrossRef
13. NAD Metabolism in Cancer Therapeutics
    Keisuke Yaku et al, 2018, Frontiers in Oncology CrossRef
14. Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
    Christine M. Heske, 2020, Frontiers in Oncology CrossRef
15. The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated
    Roumaïssa Gouasmi et al, 2022, Cancers CrossRef
16. Review of various NAMPT inhibitors for the treatment of cancer
    Yichen Wei et al, 2022, Frontiers in Pharmacology CrossRef
17. Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
    Anne-Julie Cloux et al, 2019, Oncotarget CrossRef
18. Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
    Haijun Li et al, 2017, Journal of Immunology Research CrossRef
19. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer
    Han-Yuan Liu et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
20. Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
    Katarzyna Neubauer et al, 2015, BioMed Research International CrossRef
21. NAD pool as an antitumor target against cancer stem cells in head and neck cancer
    Lola E. Navas et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef